Dynamic single-cell landscape reveals a T-cell-suppressed microenvironment and a conserved neutrophil program in the lung metastatic nicheOA
While the immune landscape of primary tumors is increasingly understood,the dy-namic immune remodeling within the evolving lung metastatic microenvironment remains poorly characterized.Here,by systematically comparing the microenvironments of primary and metastatic tumors using single-cell transcriptomics across diverse cancer models,we reveal that lung metastases consistently establish a profoundly T-cell-suppressed microenvi-ronment.Concurrently,we identified a strictly metastasis-specific neutrophil gene program.Crucially,this program is highly concurrent with the metastatic microenvironment and is fundamentally distinct from neutrophil phenotypes observed in primary tumors or healthy lungs.Among the core genes defining this program,we identified the cell surface marker STEAP4 as a highly specific indicator of these metastasis-associated neutrophils.In both murine models and human patients,these STEAP4+neutrophils were not only enriched within the local lung metastatic niche but also detectable in the circulation.Furthermore,the abundance of circulating STEAP4+neutrophils discriminates breast cancer patients with lung metastasis from those with localized primary tumors or healthy donors.Our findings delineate the divergent im-mune remodeling trajectories of lung metastasis and highlight their association with STEAP4+neutrophils,establishing a useful biological framework for future functional and mechanistic investigations.
Chen Ai;Huijuan Wu;Huihui Yang;Jing Wang;Chang Liu;Melissa S.F.Ng;Ziheng Zhou;Fenghui Zhuang;Qinhang Gao;Lingqian Wang;Changming Shi;Linnan Zhu;Zhaode Bu;Chang Chen;Lai Guan Ng;Zemin Zhang
Biomedical Pioneering Innovative Center(BIOPIC),Academy for Advanced Interdisciplinary Studies,School of Life Sciences,State Key Laboratory of Metabolic Dysregulation&Prevention and Treatment of Esophageal Cancer,Peking University,Beijing 100871,China Beijing Advanced Center of Cellular Homeostasis and Aging-Related Diseases,Institute of Advanced Clinical Medicine,Peking University,Beijing 100191,ChinaInstitute for Translational Medicine on Cell Fate and Disease,Shanghai Ninth People’s Hospital,Key Laboratory of Cell Differentiation and Apoptosis of the National Ministry of Education,Department of Pathophysiology,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China Department of Thoracic Surgery,Shanghai Pulmonary Hospital,School of Medicine,Tongji University,Shanghai 200433,China Shanghai Engineering Research Center of Lung Transplantation,Shanghai 200433,ChinaInstitute for Translational Medicine on Cell Fate and Disease,Shanghai Ninth People’s Hospital,Key Laboratory of Cell Differentiation and Apoptosis of the National Ministry of Education,Department of Pathophysiology,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaDepartment of General Surgery,First Medical Center of Chinese PLA General Hospital,Beijing 100039,ChinaBiomedical Pioneering Innovative Center(BIOPIC),Academy for Advanced Interdisciplinary Studies,School of Life Sciences,State Key Laboratory of Metabolic Dysregulation&Prevention and Treatment of Esophageal Cancer,Peking University,Beijing 100871,ChinaSingapore Immunology Network(SIgN),Agency for Science,Technology and Research(A*STAR),138648,SingaporeDepartment of Thoracic Surgery,Shanghai Pulmonary Hospital,School of Medicine,Tongji University,Shanghai 200433,China Shanghai Engineering Research Center of Lung Transplantation,Shanghai 200433,ChinaDepartment of Thoracic Surgery,Shanghai Pulmonary Hospital,School of Medicine,Tongji University,Shanghai 200433,China Shanghai Engineering Research Center of Lung Transplantation,Shanghai 200433,ChinaBiomedical Pioneering Innovative Center(BIOPIC),Academy for Advanced Interdisciplinary Studies,School of Life Sciences,State Key Laboratory of Metabolic Dysregulation&Prevention and Treatment of Esophageal Cancer,Peking University,Beijing 100871,China Changping Laboratory,Beijing 102206,ChinaDepartment of Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,ChinaShanghai Immune Therapy Institute,Shanghai Jiao Tong University School of Medicine affiliated Renji Hospital,Shanghai 200127,ChinaBiomedical Pioneering Innovative Center(BIOPIC),Academy for Advanced Interdisciplinary Studies,School of Life Sciences,State Key Laboratory of Metabolic Dysregulation&Prevention and Treatment of Esophageal Cancer,Peking University,Beijing 100871,ChinaDepartment of Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,ChinaDepartment of Thoracic Surgery,Shanghai Pulmonary Hospital,School of Medicine,Tongji University,Shanghai 200433,China Shanghai Engineering Research Center of Lung Transplantation,Shanghai 200433,ChinaSchool of Medicine,Westlake University,Hangzhou,Zhejiang 310030,China Shanghai Immune Therapy Institute,Shanghai Jiao Tong University School of Medicine affiliated Renji Hospital,Shanghai 200127,ChinaBiomedical Pioneering Innovative Center(BIOPIC),Academy for Advanced Interdisciplinary Studies,School of Life Sciences,State Key Laboratory of Metabolic Dysregulation&Prevention and Treatment of Esophageal Cancer,Peking University,Beijing 100871,China Chongqing Medical University,Chongqing 400016,China
医药卫生
Circulating biomarkersLung metastasisMetastatic nicheNeutrophil plasticitySingle-cell RNA-seqT cell suppression
《Genes & Diseases》 2026 (6)
P.579-597,19
supported by funding from the National Key Research and Development Program of China(No.2023YFF1204700)the National Natural Science Foundation of China(No.92459001,92374205,82522001,82470057,82500086)Shanghai Sailing Program(China)(No.24YF2722400)Shanghai Oriental Talent Program(China)(No.QNWS2024087)the Noncommunicable Chronic Diseases-National Science and Technology Major Project(No.2025ZD0552500).
评论